Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fluzoparib and Radioactive Particles in Advanced Soft Tissue Sarcoma
NCT05894018Phase 2Recruiting
- Start
- Jun 2023
- Primary completion
- Dec 2028
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of fluzoparib in soft tissue sarcoma (STS). Started Jun 2023; status: recruiting.
02
Drugs
fluzoparib
03
Conditions
soft tissue sarcoma (STS)
Beyond the preview
Go deeper on NCT05894018.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05894018.